AlphaYouHW
Insider selling
Howard W Robin sold $29K of Nektar Therapeutics (NKTR) stock
Howard W Robin, President & CEO of Nektar Therapeutics (NKTR), sold 444 shares of NKTR stock worth $29K, per an SEC Form 4 filed May 21, 2026.
It was an open-market sale.
The trade happened on May 19, 2026, 2 days before it was made public.
NKTR has moved -1.1% since the trade date, from $67.58 to $66.84 (Sep 21, 2026 close).
- Traded
- May 19, 2026
- Disclosed
- May 21, 2026
- Filing delay
- 2 days
- Price since
- -1.1%
- Role
- President & CEO
- Source
- SEC Form 4
More NKTR insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.